Mulica, Patrycja
Venegas, Carmen
Landoulsi, Zied
Badanjak, Katja
Delcambre, Sylvie
Tziortziou, Maria
Hezzaz, Soraya
Ghelfi, Jenny
Smajic, Semra
Schwamborn, Jens
Krüger, Rejko
Antony, Paul
May, Patrick
Glaab, Enrico
Grünewald, Anne
Pereira, Sandro L.
Funding for this research was provided by:
Luxembourg National Research Fund (PRIDE17/12244779/PARK-QC, C20/BM/14548100, INTER/DFG/19/14429377, FNR10907093, PRIDE17/12244779/PARK-QC, C19/BM/13688526, NCER-PD, INTER/DFG/19/14429377, NCER-PD, INTER/DFG/19/14429377, C19/BM/13688526)
Michael J Fox Foundation
European Union’s Horizon Europe research and innovation program
European Union’s Horizon 2020 research and innovation program (ERAPERMED 2020-314)
Luxembourg National Research Fund (FNR), NextImmune2 (PRIDE21/16749720)
Article History
Received: 17 May 2023
Accepted: 29 August 2023
First Online: 20 September 2023
Declarations
:
: The study was conducted in accordance with the institutional ethics rules (reference number of the ethics approval: ERP20-038, granted by the Ethics Review Panel of the University of Luxembourg).
: Not applicable.
: The authors declare no competing interests.